Targeting DC-SIGN with carbohydrate multivalent systems

Drug News and Perspectives

Volumn 23, Issue 9, 2010, Pages 557-572

  Sánchez Navarro, Macarena ^a   Rojo, Javier ^a  

^a INSTITUTO DE INVESTIGACIONES QUÍMICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CD209 ANTIGEN; TUMOR VACCINE; VIRUS VACCINE; CANCER VACCINE; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN; VACCINE;

ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; CELL STIMULATION; CROSS PRESENTATION; DENDRITIC CELL; DISEASE SEVERITY; HUMAN; IC 50; IMMUNE RESPONSE; INTERNALIZATION; LIPOSOMAL DELIVERY; NONHUMAN; PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS IMMUNITY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; IMMUNOLOGY; METABOLISM; NEOPLASM; VIRUS INFECTION;

ANIMALS; CANCER VACCINES; CARBOHYDRATES; CELL ADHESION MOLECULES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LECTINS, C-TYPE; NEOPLASMS; RECEPTORS, CELL SURFACE; VACCINES; VIRUS DISEASES;

EID: 79952279325     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2010.23.9.1437246     Document Type: Review

References (63)

1. Curtis, B.M., Scharnowske, S., Watson, A.J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A 1992, 89(17): 8356-60.
2. Geijtenbeek, T.B., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C., Adema, G.J., van Kooyk, Y., Figdor, C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100(5): 575-85.
3. Geijtenbeek, T.B., Kwon, D.S., Torensma, R. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100(5): 587-97.
4. Mitchell, D.A., Fadden, A.J., Drickamer, K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 2001, 276(31): 28939-45.
5. Pohlmann, S., Baribaud, F., Doms, R.W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol 2001, 22(12): 643-6.
6. Feinberg, H., Guo, Y., Mitchell, D.A., Drickamer, K., Weis, W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 2005, 280(2): 1327-35.
7. Snyder, G.A., Colonna, M., Sun, P.D. The structure of DC-SIGNR with a portion of its repeat domain lends insights to modeling of the receptor tetramer. J Mol Biol 2005, 347(5): 979-89. (Pubitemid 40387446)
8. Serrano-Gomez, D., Sierra-Filardi, E., Martinez-Nunez, R.T. et al. Structural requirements for multimerization of the pathogen receptor dendritic cell-specific ICAM3-grabbing non-integrin (CD209) on the cell surface. J Biol Chem 2008, 283(7): 3889-903.
9. Tabarani, G., Thepaut, M., Stroebel, D. et al. DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain. J Biol Chem 2009, 284(32): 21229-40.
10. van Kooyk, Y., Geijtenbeek, T.B. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003, 3(9): 697-709.
11. Geijtenbeek, T.B., van Kooyk, Y. Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 2003, 111(7-8): 698-714. (Pubitemid 37130018)
12. van Die, I., van Vliet, S.J., Nyame, A.K. et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003, 13(6): 471-8. (Pubitemid 36665421)
13. Appelmelk, B.J., van Die, I., van Vliet, S.J., Vandenbroucke-Grauls, C.M., Geijtenbeek, T.B., van Kooyk, Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003, 170(4): 1635-9. (Pubitemid 36197376)
14. Naarding, M.A., Ludwig, I.S., Groot, F., Berkhout, B., Geijtenbeek, T.B., Pollakis, G., Paxton, W.A. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005, 115(11): 3256-64. (Pubitemid 41567590)
15. van Liempt, E., Bank, C.M., Mehta, P. et al. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett 2006, 580(26): 6123-31. (Pubitemid 44666793)
16. Feinberg, H., Mitchell, D.A., Drickamer, K., Weis, W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 2001, 294(5549): 2163-6. (Pubitemid 33150672)
17. Guo, Y., Feinberg, H., Conroy, E. et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 2004, 11(7): 591-8. (Pubitemid 38823524)
18. Feinberg, H., Castelli, R., Drickamer, K., Seeberger, P.H., Weis, W.I. Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J Biol Chem 2007, 282(6): 4202-9. (Pubitemid 47084456)
19. Reina, J.J., Diaz, I., Nieto, P.M. et al. Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin. Org Biomol Chem 2008, 6(15): 2743-54. (Pubitemid 352027704)
20. Angulo, J., Diaz, I., Reina, J.J., Tabarani, G., Fieschi, F., Rojo, J., Nieto, P.M. Saturation transfer difference (STD) NMR spectroscopy characterization of dual binding mode of a mannose disaccharide to DC-SIGN. Chembiochem 2008, 9(14): 2225-7.
21. Cambi, A., de Lange, F., van Maarseveen, N.M. et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol 2004, 164(1): 145-55. (Pubitemid 38082465)
22. de Bakker, B.I., de Lange, F., Cambi, A. et al. Nanoscale organization of the pathogen receptor DC-SIGN mapped by single-molecule high-resolution fluorescence microscopy. Chemphyschem 2007, 8(10): 1473-80.
23. Neumann, A.K., Thompson, N.L., Jacobson, K. Distribution and lateral mobility of DC-SIGN on immature dendritic cells-implications for pathogen uptake. J Cell Sci 2008, 121(Pt 5): 634-43. (Pubitemid 351524162)
24. Brode, S., Macary, P.A. Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 2004, 112(3): 345-51.
25. Moron, G., Dadaglio, G., Leclerc, C. New tools for antigen delivery to the MHC class I pathway. Trends Immunol 2004, 25(2): 92-7. (Pubitemid 38167490)
26. Guermonprez, P., Amigorena, S. Pathways for antigen cross presentation. Springer Semin Immunopathol 2005, 26(3): 257-71.
27. Blanchard, N., Shastri, N. Cross-presentation of peptides from intracellular pathogens by MHC class I molecules. Ann N Y Acad Sci 2010, 1183: 237-50.
28. Banchereau, J., Steinman, R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673): 245-52. (Pubitemid 28155090)
29. Thery, C., Amigorena, S. The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol 2001, 13(1): 45-51. (Pubitemid 32096959)
30. Mellman, I., Steinman, R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106(3): 255-8. (Pubitemid 32772607)
31. Zhou, T., Chen, Y., Hao, L., Zhang, Y. DC-SIGN and immunoregulation. Cell Mol Immunol 2006, 3(4): 279-83.
32. Caparros, E., Munoz, P., Sierra-Filardi, E. et al. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006, 107(10): 3950-8. (Pubitemid 43726801)
33. Shan, M., Klasse, P.J., Banerjee, K. et al. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog 2007, 3(11): e169.
34. van Kooyk, Y. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans 2008, 36(Pt 6): 1478-81.
35. den Dunnen, J., Gringhuis, S.I., Geijtenbeek, T.B. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother 2009, 58(7): 1149-57.
36. Geijtenbeek, T.B., den Dunnen, J., Gringhuis, S.I. Pathogen recognition by DC-SIGN shapes adaptive immunity. Future Microbiol 2009, 4: 879-90.
37. Gringhuis, S.I., den Dunnen, J., Litjens, M., van der Vlist, M., Geijtenbeek, T.B. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 2009, 10(10): 1081-8.
38. den Dunnen, J., Gringhuis, S.I., Geijtenbeek, T.B. Dusting the sugar fingerprint: C-type lectin signaling in adaptive immunity. Immunol Lett 2010, 128(1): 12-6.
39. Engering, A.J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E.C., Lanzavecchia, A., Pieters, J. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 1997, 27(9): 2417-25. (Pubitemid 27404329)
40. Tan, M.C., Mommaas, A.M., Drijfhout, J.W. et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 1997, 27(9): 2426-35. (Pubitemid 27404330)
41. Grandjean, C., Rommens, C., Gras-Masse, H., Melnyk, O. One-pot synthesis of antigen-bearing, lysine-based cluster mannosides using two orthogonal chemoselective ligation reactions. Angew Chem Int Ed Engl 2000, 39(6): 1068-72. (Pubitemid 30217248)
42. Grandjean, C., Angyalosi, G., Loing, E. et al. Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic or shikimic acid derivatives as mannose bioisosteres. Chembiochem 2001, 2(10): 747-57.
43. Chenevier, P., Grandjean, C., Loing, E. et al. Grafting of synthetic mannose receptor-ligands onto onion vectors for human dendritic cells targeting. Chem Commun (Camb) 2002(20): 2446-7.
44. Frison, N., Taylor, M.E., Soilleux, E. et al. Oligolysine-based oligosaccharide clusters: selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin. J Biol Chem 2003, 278(26): 23922-9.
45. Srinivas, O., Larrieu, P., Duverger, E. et al. Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting. Bioconjug Chem 2007, 18(5): 1547-54.
46. Lam, J.S., Mansour, M.K., Specht, C.A., Levitz, S.M. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 2005, 175(11): 7496-503.
47. Lam, J.S., Huang, H., Levitz, S.M. Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS One 2007, 2(10): e1009.
48. Kel, J.M., de Geus, E.D., van Stipdonk, M.J., Drijfhout, J.W., Koning, F., Nagelkerken, L. Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. Int Immunol 2008, 20(1): 117-27.
49. Kantchev, E.A., Chang, C.C., Cheng, S.F., Roche, A.C., Chang, D.K. Direct solid-phase synthesis and fluorescence labeling of large, monodisperse mannosylated dendrons in a peptide synthesizer. Org Biomol Chem 2008, 6(8): 1377-85.
50. Espuelas, S., Thumann, C., Heurtault, B., Schuber, F., Frisch, B. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Bioconjug Chem 2008, 19(12): 2385-93.
51. Adams, E.W., Ratner, D.M., Seeberger, P.H., Hacohen, N. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Chembiochem 2008, 9(2): 294-303.
52. Wang, J., Zhang, Y., Wei, J. et al. Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 2007, 121(2): 174-82.
53. Singh, S.K., Stephani, J., Schaefer, M. et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol Immunol 2009, 47(2-3): 164-74.
54. Sheng, K.C., Kalkanidis, M., Pouniotis, D.S., Esparon, S., Tang, C.K., Apostolopoulos, V., Pietersz, G.A. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur J Immunol 2008, 38(2): 424-36.
55. Greatrex, B.W., Brodie, S.J., Furneaux, R.H. et al. The synthesis and immune stimulating action of mannose-capped lysine-based dendrimers. Tetrahedron 2009, 65(15): 2939-50.
56. Wang, S.K., Liang, P.H., Astronomo, R.D., Hsu, T.L., Hsieh, S.L., Burton, D.R., Wong, C.H. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc Natl Acad Sci U S A 2008, 105(10): 3690-5.
57. Martinez-Avila, O., Hijazi, K., Marradi, M., Clavel, C., Campion, C., Kelly, C., Penades, S. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. Chemistry 2009, 15(38): 9874-88.
58. Martinez-Avila, O., Bedoya, L.M., Marradi, M., Clavel, C., Alcami, J., Penades, S. Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. Chembiochem 2009, 10(11): 1806-9.
59. Arce, E., Nieto, P.M., Diaz, V., Castro, R.G., Bernad, A., Rojo, J. Glycodendritic structures based on Boltorn hyperbranched polymers and their interactions with Lens culinaris lectin. Bioconjug Chem 2003, 14(4): 817-23.
60. Lasala, F., Arce, E., Otero, J.R., Rojo, J., Delgado, R. Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans. Antimicrob Agents Chemother 2003, 47(12): 3970-2.
61. Rojo, J., Delgado, R. Glycodendritic structures: promising new antiviral drugs. J Antimicrob Chemother 2004, 54(3): 579-81.
62. Tabarani, G., Reina, J.J., Ebel, C., Vives, C., Lortat-Jacob, H., Rojo, J., Fieschi, F. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding. FEBS Lett 2006, 580(10): 2402-8.
63. Sattin, S., Daghetti, A., Thepaut, M. et al. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. ACS Chem Biol 2010, 5(3): 301-12.